Investments
7Portfolio Exits
2Latest WTT Investment News
Sep 16, 2021
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures. Participating in the round were NEA, Temasek, Pavilion Capital, Brandon Capital Partners, Vertex Growth, Vertex Ventures HC, and WTT Investment Ltd. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
WTT Investment Investments
7 Investments
WTT Investment has made 7 investments. Their latest investment was in Ignis Therapeutics as part of their Series A on November 11, 2021.
WTT Investment Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/11/2021 | Series A | Ignis Therapeutics | $180M | Yes | 6 | |
9/15/2021 | Series C | |||||
7/28/2021 | Series A | |||||
11/17/2020 | Series B | |||||
7/24/2020 | Series B |
Date | 11/11/2021 | 9/15/2021 | 7/28/2021 | 11/17/2020 | 7/24/2020 |
|---|---|---|---|---|---|
Round | Series A | Series C | Series A | Series B | Series B |
Company | Ignis Therapeutics | ||||
Amount | $180M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 6 |
WTT Investment Portfolio Exits
2 Portfolio Exits
WTT Investment has 2 portfolio exits. Their latest portfolio exit was Beyond Meat on May 02, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/2/2019 | IPO | 7 | |||
Date | 5/2/2019 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 7 |